Ala Wai Pharma Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Ala Wai Pharma General Information

Description

Developer of drug delivery systems designed to increase the effectiveness of influenza drugs. The company's delivery systems focus on methodologies which target permeability and the portion of the drug activated upon entering the blood stream, enabling patients to receive better results from medications.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 2444 Dole Street
  • Bachman 105
  • Honolulu, HI 96822
  • United States
+1 (808)
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 2444 Dole Street
  • Bachman 105
  • Honolulu, HI 96822
  • United States
+1 (808)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ala Wai Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Feb-2021 Completed Startup
2. Early Stage VC 05-Aug-2013 Completed Startup
1. Seed Round 01-Dec-2011 $300K $300K Completed Startup
To view Ala Wai Pharma’s complete valuation and funding history, request access »

Ala Wai Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Ala Wai Pharma’s complete cap table history, request access »

Ala Wai Pharma Patents

Ala Wai Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140314857-A1 Formulations for enhanced bioavailability of zanamivir Inactive 05-Jan-2012
WO-2013103668-A1 Formulations for enhanced bioavailability of zanamivir Inactive 05-Jan-2012
AU-2008324787-A1 Formulations for enhanced bioavailability of orally administered polar agents Active 05-Nov-2007
AU-2008324787-B2 Formulations for enhanced bioavailability of orally administered polar agents Inactive 05-Nov-2007
AU-2014200052-A1 Formulations for enhanced bioavailability of orally administered polar agents Active 05-Nov-2007
To view Ala Wai Pharma’s complete patent history, request access »

Ala Wai Pharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
University of Hawaii Foundation Limited Partner Minority
To view Ala Wai Pharma’s complete investors history, request access »

Ala Wai Pharma FAQs

  • When was Ala Wai Pharma founded?

    Ala Wai Pharma was founded in 2011.

  • Where is Ala Wai Pharma headquartered?

    Ala Wai Pharma is headquartered in Honolulu, HI.

  • What industry is Ala Wai Pharma in?

    Ala Wai Pharma’s primary industry is Drug Delivery.

  • Is Ala Wai Pharma a private or public company?

    Ala Wai Pharma is a Private company.

  • What is Ala Wai Pharma’s current revenue?

    The current revenue for Ala Wai Pharma is .

  • How much funding has Ala Wai Pharma raised over time?

    Ala Wai Pharma has raised $800K.

  • Who are Ala Wai Pharma’s investors?

    University of Hawaii Foundation has invested in Ala Wai Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process